Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia. 1981

R J Piroli, and G T Passananti, and C A Shively, and E S Vesell

In a subject with the rare condition of idiopathic hypoalbuminemia, antipyrine and warfarin disposition was investigated to determine whether, in an otherwise healthy subject, low albumin concentrations affect the kinetics of these prototypic drugs. Because antipyrine is negligibly bound to albumin its disposition would be expected to be normal, but because at usual therapeutic doses warfarin is 99% bound to albumin, warfarin elimination would be expected to be accelerated in idiopathic hypoalbuminemia. In our patient antipyrine disposition was normal, whereas warfarin clearance was increased and plasma warfarin half-life reduced. The apparent volume of distribution of warfarin was within normal range. Warfarin binding to the patient's plasma was decreased; the free fraction of warfarin in plasma was correspondingly elevated. Albumin isolated from the patient and purified exhibited kinetic values for warfarin binding. Caution is necessary in extending these results to other drugs and other patients with idiopathic hypoalbuminemia since the validity of such extrapolations depends on the extent to which the drug investigated is normally bound to albumin and also on the magnitude of the particular patient's hypoalbuminemia at the precise time of study.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
January 1978, East African medical journal,
R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
January 1988, Pharmacology,
R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
March 1978, British journal of clinical pharmacology,
R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
January 1986, Cancer chemotherapy and pharmacology,
R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
April 1995, Journal of veterinary pharmacology and therapeutics,
R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
January 1991, Pharmacotherapy,
R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
December 1987, British journal of clinical pharmacology,
R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
November 1977, Cancer research,
R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
July 1954, Helvetica paediatrica acta,
R J Piroli, and G T Passananti, and C A Shively, and E S Vesell
March 1979, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!